Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,035,506,044
+$441,867,475 QoQ
Shares Held
1,697,061
-2.1% QoQ
Ownership
0.180%
of shares outstanding
% of Portfolio
1.43%
of 13F equity value
Holder Rank
#54
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$2,998,575
PutShares
2,500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026NEUBERGER BERMAN GROUP LLC holds $5,124,714,999 across 15 Drug Manufacturers - General names. LLY ranks #1 (39.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,697,061 | $2,035,506,044 | |
| 2 | JNJ |
Johnson & Johnson
|
4,126,113 | $1,047,908,917 | |
| 3 | AZN |
Astrazeneca PLC
|
2,746,590 | $520,808,395 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,533,955 | $454,113,217 | |
| 5 | ABBV |
AbbVie Inc.
|
1,279,175 | $321,891,596 | |
| 6 | PFE |
Pfizer Inc
|
10,281,652 | $247,582,179 | |
| 7 | AMGN |
Amgen Inc
|
646,798 | $234,218,491 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,361,825 | $172,052,970 |
All Filings in LLY
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,998,575 | 2,500 | Put | Defined | 2026-08-13 | |
| 2026-06-30 | $2,035,506,044 | 1,697,061 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,593,638,569 | 1,732,649 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $1,909,481,929 | 1,776,791 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,333,888,045 | 1,748,215 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $1,212,929,191 | 1,555,975 | Shares | Defined | 2025-08-25 | |
| 2025-03-31 | $1,253,975,849 | 1,518,296 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $1,125,123,608 | 1,457,414 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $1,274,443,294 | 1,438,521 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,312,391,767 | 1,449,548 | Shares | Defined | 2024-11-14 | |
| 2024-03-31 | $1,083,177,824 | 1,392,331 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $843,520,215 | 1,447,060 | Shares | Defined | 2024-11-14 | |
| 2023-09-30 | $807,670,563 | 1,503,678 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $688,619,279 | 1,468,334 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $482,886,982 | 1,406,112 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $486,896,821 | 1,330,901 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $437,077,368 | 1,351,716 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $445,070,844 | 1,372,701 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $380,789,625 | 1,329,712 | Shares | Defined | 2022-05-23 | |
| 2021-12-31 | $357,792,185 | 1,295,316 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $206,899,497 | 895,475 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $212,346,165 | 925,175 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $165,103,295 | 883,756 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $160,748,342 | 952,075 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $147,303,582 | 995,160 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $158,912,119 | 967,914 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $134,671,456 | 970,815 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||